Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 19/20 | 0.73 |
| ▸ | ADRA2A | P08913 | 12/20 | 0.73 |
| ▸ | HTR2B | P41595 | 9/20 | 0.73 |
| ▸ | HRH1 | P35367 | 8/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.59 |
| ▸ | HTR1A | P08908 | 2/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6877184 | 1.00 | MCHR1 (0.73) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6874979 | 0.90 | MCHR1 (0.61) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6874968 | 0.90 | MCHR1 (0.61) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6878301 | 0.87 | MCHR1 (0.75) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6878309 | 0.87 | MCHR1 (0.75) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6458177 | 0.85 | MCHR1 (1.00) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6458186 | 0.85 | MCHR1 (1.00) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6463166 | 0.82 | MCHR1 (0.82) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| SCHEMBL6463156 | 0.82 | MCHR1 (0.82) | MCHR1ADRA2AHTR2BHRH1ADRA1A | |
| Trifluoroacetic Acid SCHEMBL6460375 | 0.82 | MCHR1 (0.53) | MCHR1ADRA2AHTR2BHRH1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |